Recent studies showed that increased pulmonary ECs apoptosis caused by loss-of-function mutations in bone morphogenetic protein receptor-2 (BMPR2) may represent a possible initiating mechanism in PAH, [13]. Here, BMPR2 is linked to pulmonary arterial hypertension.